NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $210,000 | -19.2% | 1,504 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $260,000 | +23.8% | 1,504 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $210,000 | +4.0% | 1,504 | -32.3% | 0.01% | 0.0% |
| Q3 2017 | $202,000 | -83.7% | 2,220 | -86.6% | 0.01% | -85.3% |
| Q2 2017 | $1,237,000 | +5.4% | 16,623 | +2.9% | 0.03% | 0.0% |
| Q4 2016 | $1,174,000 | +6.2% | 16,155 | -17.8% | 0.03% | 0.0% |
| Q1 2016 | $1,105,000 | +6.2% | 19,642 | -12.3% | 0.03% | +6.2% |
| Q3 2015 | $1,040,000 | +30.2% | 22,402 | +50.7% | 0.03% | +45.5% |
| Q2 2015 | $799,000 | +78.7% | 14,864 | +59.1% | 0.02% | +83.3% |
| Q1 2015 | $447,000 | -31.9% | 9,342 | -44.9% | 0.01% | -36.8% |
| Q4 2014 | $656,000 | – | 16,948 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |